Clinical trial
Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With…
NCT00000392 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00000392 |
|---|---|
| Title | Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment. |
| Official title | Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment. |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Cognition Disorders |
| Intervention type | Drug |
| Interventions | Peptide T, Placebo |
| Enrollment | 215 |
| Start date | Jan 1, 1990 |
| Primary completion | Aug 1, 1996 |
| Completion | Aug 1, 1996 |
| First posted | Jan 18, 2000 |
| Last update posted | Feb 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: